Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

APALUTAMIDE vs APREPITANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

APALUTAMIDE vs APREPITANT: Safety Overview

Metric APALUTAMIDE APREPITANT
Total FAERS Reports 9,545 5,620
Deaths Reported 1,286 1,195
Death Rate 13.5% 21.3%
Hospitalizations 2,136 2,917
Average Patient Age 76.5 yrs 52.8 yrs
% Female Patients 0.4% 70.9%
FDA Approval Date Feb 14, 2018 Dec 17, 2015
Manufacturer Janssen Products, LP Heron Therapeutics, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription